Company: BIAF
Filing Date: 2025-09-15
Form Type: S-1/A
Source: 0001493152-25-013294
Chunk: 21

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-09-15
Form: S-1/A
Chunk 21
---
 exercise of the May 2025 Warrants. The shares listed in the second column consist of (i)                 
 the aforementioned shares and (ii) 3,340,406 shares of Common Stock issuable upon exercise of common stock purchase warrants                  
 that were initially issued as registered securities and are not being registered for resale hereunder. Michael Bigger is the                  
 managing member of Bigger Capital Fund, LP and has voting control and investment discretion over securities beneficially owned directly       
 by Bigger Capital Fund, LP and has voting control and investment discretion over securities beneficially owned directly by Bigger             
 Capital Fund, LP. In such role, Mr. Bigger may be deemed to beneficially own the securities owned by Bigger Capital Fund, LP. We              
 have been advised that none of Mr. Bigger or Bigger Capital Fund, LP is a member of the Financial Industry Regulatory Authority,              
 or FINRA, or an independent broker-dealer, an affiliate or associated person of a FINRA member, or an affiliate of a broker-dealer.           
 The foregoing should not be construed in and of itself as an admission by Mr. Bigger or Bigger Capital Fund, LP as to beneficial              
 ownership of the securities beneficially owned directly by Bigger Capital Fund, LP. The business address of Bigger Capital Fund,              
 LP is 11700 W Charleston Blvd. 170-659, Las Vegas, NV 89135.                                                                                  |
| (6) | The                                                                                                                                           
 shares listed in the third column consist of (i) 391,304 shares of Common Stock issuable upon conversion of 90 shares of Series               
 B Preferred Stock, (ii) 610,434 shares of Common Stock issuable upon exercise of Private Warrants and (iii) 631,250 shares                    
 of Common Stock issuable upon exercise of the May 2025 Warrants The shares listed in the second column consist of (i)                         
 the aforementioned shares and (ii) 468,750 shares of Common Stock issuable upon exercise of common stock purchase warrants                    
 that were initially issued as registered securities and are not being registered for resale hereunder. Mr. Graber has voting                  
 control and investment discretion over securities beneficially owned. In such role, We have been advised that Mr. Graber is not a             
 member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, an affiliate or associated person           
 of a FINRA member, or an affiliate of a broker-dealer. The business address of